Do Not Let a Paperwork ‘Gotcha’ Sink Valuable Medicines

Congress is considering a bill that would let patents on prescription drugs be rendered unenforceable over an honest paperwork error, even when the underlying invention is genuinely new, non-obvious, and valuable to patients. Supporters of the Medication Affordability and Patent Integrity Act (S. 2658), which the Senate Health, Education, Labor, and Pensions Committee reported in July, say it will lower drug prices by closing what they describe as a loophole that drugmakers use to extend their monopolies.

SCOTUS Summarily Affirms Fifth Circuit Judgment on Worldwide Copyright Reversion

The U.S. Supreme Court issued an order on Monday in BMG Rights Management (US) LLC v. Vetter affirming the U.S. Court of Appeals for the Fifth Circuit’s judgment granting a songwriter ownership of the worldwide copyright in “Double Shot (Of My Baby’s Love).” The Court entered the affirmance under 28 U.S.C. Section 2109, following a September 30 reply in which BMG Rights Management (US) LLC and the other petitioners urged the Court to grant certiorari and reverse.

Venable LLP is Seeking a Trademark Associate (Mid-Level)

Venable LLP’s Intellectual Property Group is seeking a mid-level associate with five to seven years of substantive U.S. trademark experience in a law firm setting to join our practice in Washington, D.C. Our team advises and represents clients across the full spectrum of trademark and brand protection law, including prosecution, clearance, enforcement, portfolio management, and proceedings before the Trademark Trial and Appeal Board (TTAB).

The Patent Disclosure Trap: Will AI Undermine Biopharmaceutical Innovation?

Artificial intelligence could help deliver the next generation of lifesaving medicines. It could also weaken the economic foundation that makes discovering those medicines possible. Both propositions deserve serious attention, and neither is mutually exclusive. Celebrating faster discovery tells only part of the story if the same technology allows competitors to appropriate the commercial opportunity created by pioneer research or obtain patent claims that obstruct the innovator’s next steps.

SCOTUS Heeds SG’s Call to Deny Google’s Challenge of PTAB Settled Expectations Doctrine

On Monday, the U.S. Supreme Court issued an order list that included a denial of Google’s petition for writ of certiorari challenging the U.S. Patent and Trademark Office’s (USPTO’s) development of settled expectations doctrine at the Patent Trial and Appeal Board (PTAB). This latest setback to industry-wide efforts opposing the duration of a patent’s life in force as a consideration leading to discretionary denials of inter partes review (IPR) proceedings comes a few weeks after the U.S. Solicitor General urged denial of Google’s cert petition, agreeing with the Federal Circuit that such a challenge was not available on mandamus review.

SCOTUS Ends Decade Long Copyright Case Against State of North Carolina

The U.S. Supreme Court on Monday denied certiorari in Frederick L. Allen, et al. v. Joshua Stein, Governor of North Carolina, a decade-plus long case that led to a Supreme Court decision as well as the introduction and subsequent repeal of a law to shield North Carolina from copyright liability. In January 2026, the U.S. Court of Appeals for the Fourth Circuit issued the most recent ruling in the case, which related to Frederick (“Rick) Allen’s copyright battle against the State of North Carolina over documentary footage of a state-sponsored salvage project exhuming a shipwreck associated with the famed pirate, Blackbeard. Videographer Frederick Allen and his company Nautilus Productions recorded footage of a private company’s project to salvage Blackbeard’s flagship Queen Anne’s Revenge from the North Carolina coastline.

Patent Value and Licensing Price: What is a Patent Really Worth?| IPWatchdog Unleashed

A patent’s economic value and the price it commands in a licensing negotiation can be very different things. The technology may deliver substantial commercial benefits, yet the amount a patent owner can capture depends on legal risk, enforcement costs, negotiating leverage, and each party’s business objectives. This week on IPWatchdog Unleashed, we ask how much a patent is really worth, and how to prove it at a negotiating table or in court. This conversation, which occurred as part of IPWatchdog’s 2026 Women’s IP Forum, examines how sophisticated licensors, licensees, counsel, and valuation professionals assess patent value in real-world transactions and disputes. The conversation explored royalty structures, comparable licenses, portfolio strength, litigation and validity risk, damages principles, standard-essential patent (SEP) licensing, and the practical factors that drive parties toward—or away from—a deal.

Subscribe to IPWatchdog

This is the best way to stay informed. We send a daily roundup of our latest news, press releases, and events.

Get Email Updates